{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:52:08Z","timestamp":1778626328893,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2018,2,9]]},"DOI":"10.2174\/1381612823666170809100524","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T02:14:55Z","timestamp":1502936095000},"page":"5593-5605","source":"Crossref","is-referenced-by-count":11,"title":["Antiepileptic Drugs in Clinical Development: Differentiate or Die?"],"prefix":"10.2174","volume":"23","author":[{"given":"Gaetano","family":"Zaccara","sequence":"first","affiliation":[{"name":"Unit of Neurology, San Giovanni di Dio Hospital, Via Di Torregalli n 3, 50143, Firenze,, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Epilepsy Research Group Berlin, Berlin,, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/154779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T07:44:00Z","timestamp":1518594240000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/154779\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":0,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2018,2,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612823666170809100524","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2,9]]}}}